GlassScriptPhysician profile
Charlene A Ray
NPI 1528163599
$828.97
in general payments reported to CMS, 2019-2025
23 companies · $33.93 in 2025
The $33.93 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $445 · 2022: $333 · 2023: $17.08 · 2025: $33.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $51.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $51.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $112.62 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $111.17 | 2021-2022 | |
| Exelixis INC. | $76.46 | 2021-2022 | |
| Janssen Biotech, INC. | $67.57 | 2021 | |
| Seagen INC. | $59.62 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $56.67 | 2021-2022 | |
| Glaxosmithkline, LLC. | $38.54 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $33.93 | 2025 | Mammomat B.Brilliant, Acuson Sequoia Diagnostic Ultrasound System |
| Takeda Pharmaceuticals U.S.A., INC. | $27.01 | 2021 | |
| Lilly USA, LLC | $26.17 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $24.82 | 2022 | |
| Eusa Pharma (US) LLC | $23.46 | 2021 | |
| Adc Therapeutics America, INC. | $19.83 | 2022 | |
| Organon LLC | $18.08 | 2022 | |
| Sobi, INC | $17.08 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| G1 Therapeutics, INC. | $16.79 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $16.18 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.78 | 2021 | |
| Genentech USA, INC. | $15.38 | 2022 | |
| Amgen INC. | $14.07 | 2021 | |
| Eisai INC. | $13.84 | 2021 | |
| Myovant Sciences INC. | $12.06 | 2022 | |
| Tersera Therapeutics LLC | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charlene Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.